Improvement of endothelial function of the corpus cavernosum in apolipoprotein E knockout mice treated with irbesartan

Journal of Pharmacology and Experimental Therapeutics

Volumn 327, Issue 3, 2008, Pages 692-698

  Baumhäkel, Magnus ^a   Custodis, Florian ^a   Schlimmer, Nils ^a   Laufs, Ulrich ^a   Böhm, Michael ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR; APOLIPOPROTEIN E; HYDRALAZINE; IRBESARTAN; LIPID PEROXIDASE; NITRIC OXIDE; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BIOSYNTHESIS; BLOOD PRESSURE MEASUREMENT; CHOLESTEROL DIET; CONTROLLED STUDY; CORPUS CAVERNOSUM; DRUG MECHANISM; ENDOTHELIUM; ENZYME ASSAY; ERECTILE DYSFUNCTION; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LIPID DIET; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PARAMETER; PENIS ERECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASCULAR RING; WILD TYPE;

ANIMALS; AORTA; APOLIPOPROTEINS E; BIPHENYL COMPOUNDS; BLOOD PRESSURE; ENDOTHELIUM; ENDOTHELIUM, VASCULAR; HYDRALAZINE; MALE; MICE; MICE, KNOCKOUT; NITRIC OXIDE; OXIDATIVE STRESS; PENILE ERECTION; PENIS; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM; TETRAZOLES;

EID: 57549099686     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.140533     Document Type: Article

References (29)

1. Baumhäkel M and Böhm M (2007) Erectile dysfunction correlates with left ventricular function and precedes cardiovascular events in cardiovascular high-risk patients. Int J Clin Pract 61:361-366.
2. Becker AJ, Uckert S, Stief CG, Truss MC, Machtens S, Scheller F, Knapp WH, Hartmann U, and Jonas U (2001) Possible role of bradykinin and angiotensin II in the regulation of penile erection and detumescence. Urology 57:193-198.
3. Beere PA, Glagov S, and Zarins CK (1984) Retarding effect of lowered heart rate on coronary atherosclerosis. Science 226:180-182.
4. Behr-Roussel D, Darblade B, Oudot A, Compagnie S, Bernabé J, Alexandre L, and Giuliano F (2006) Erectile dysfunction in hypercholesterolemic atherosclerotic apolipoprotein E knockout mice. J Sex Med 3:596-603.
5. Böhm M, Baumhäkel M, Probstfield JL, Schmieder R, Yusuf S, Zhao F, and Koon T (2007) Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients: sub-study of the ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNT Study in ACE-INtolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND). Am Heart J 154:94-101.
6. Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, and Engelmann U (2000) Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. Int J Impot Res 12:305-311.
7. Büyükafşar K and Un I (2003) Effects of the Rho-kinase inhibitors, Y-27632 and fasudil, on the corpus cavernosum from diabetic mice. Eur J Pharmacol 472:235-238.
8. Candido R, Allen TJ, Lassila M, Cao Z, Thallas V, Cooper ME, and Jandeleit-Dahm KA (2004) Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis. Circulation 109:1536-1542.
9. Dusing R (2003) Effect of the angiotensin II antagonist valsartan on sexual function in hypertensive men. Blood Press Suppl 2:29-34.
10. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, and McKinlay JB (1994) Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 151:54-61.
11. Fogari R, Zoppi A, Corradi L, Mugellini A, Poletti L, and Lusardi P (1998) Sexual function in hypertensive males treated with lisinopril or atenolol: a cross-over study. Am J Hypertens 11:1244-1247.
12. Fogari R, Zoppi A, Poletti L, Marasi G, Mugellini A, and Corradi L (2001) Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study. Am J Hypertens 14:27-31.
13. Friedrich EB, Teo KK, and Böhm M (2006) ACE inhibition in secondary prevention: are the results controversial? Clin Res Cardiol 95:61-67.
14. Griendling KK, Minieri CA, Ollerenshaw JD, and Alexander RW (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74:1141-1148.
15. Hale TM, Okabe H, Bushfield TL, Heaton JP, and Adams MA (2002) Recovery of erectile function after brief aggressive antihypertensive therapy. J Urol 168:348-354.
16. Harrison DG (1997) Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 100:2153-2157.
17. Kifor I, Williams GH, Vickers MA, Sullivan MP, Jodbert P, and Dluhy RG (1997) Tissue angiotensin II as a modulator of erectile function. I. Angiotensin peptide content, secretion and effects in the corpus cavernosum. J Urol 157:1920-1925.
18. Laufs U, Wassmann S, Czech T, Münzel T, Eisenhauer M, Böhm M, and Nickenig G (2005) Physical inactivity increases oxidative stress, endothelial dysfunction, and atherosclerosis. Arterioscler Thromb Vasc Biol 25:809-814.
19. Llisterri JL, Lozano Vidal JV, Aznar Vicente J, Argaya Roca M, Pol Bravo C, Sanchez Zamorano MA, and Ferrario CM (2001) Sexual dysfunction in hypertensive patients treated with losartan. Am J Med Sci 321:336-341.
20. Modebe O (1990) Erectile failure among medical clinic patients. Afr J Med Med Sci 19:259-264.
21. Müller SC, el-Damanhoury H, Rüth J, and Lue TF (1991) Hypertension and impotence. Eur Urol 19:29-34.
22. NIH Consensus Development Panel on Impotence (1993) NIH Consensus Conference. Impotence. JAMA 270:83-90.
23. Nickenig G, Jung O, Strehlow K, Zolk O, Linz W, Schölkens BA, and Böhm M (1997) Hypercholesterolemia is associated with enhanced angiotensin AT1-receptor expression. Am J Physiol 272:H2701-H2707.
24. Nickenig G, Strehlow K, Wassmann S, Bäumer AT, Albory K, Sauer H, and Böhm M (2000) Differential effects of estrogen and progesterone on AT(1) receptor gene expression in vascular smooth muscle cells. Circulation 102:1828-1833.
25. Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman BA, Griendling KK, and Harrison DG (1996) Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97:1916-1923.
26. Warnholtz A, Nickenig G, Schulz E, Macharzina R, Bräsen JH, Skatchkov M, Heitzer T, Stasch JP, Griendling KK, Harrison DG, et al. (1999) Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation 99:2027-2033.
27. Wassmann S, Czech T, van Eickels M, Fleming I, Böhm M, and Nickenig G (2004) Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice. Circulation 110:3062-3067.
28. Xie D, Odronic SI, Wu F, Pippen AM, Donatucci CF, and Annex BH (2007) A mouse model of hypercholesterolemia-induced erectile dysfunction. J Sex Med 4:898-907.
29. Yavuzgil O, Altay B, Zoghi M, Gürgün C, Kayikçioǧ lu M, and Kültürsay H (2005) Endothelial function in patients with vasculogenic erectile dysfunction. Int J Cardiol 103:19-26.